Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASPAR: Clopidogrel in Below-Knee Bypass
NCT00174759Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of clopidogrel in Peripheral Arterial Disease (PAD), sponsored by Sanofi. Started Sep 2004; status: completed.
02
Drugs
clopidogrel
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00174759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174759.